Mirum Pharmaceuticals, Inc.
DE ˙ DB ˙ US6047491013
77,12 € ↑0,96 (1,26%)
2026-06-05
DEL PRIS
SecurityDE:08D / Mirum Pharmaceuticals, Inc.
InstitutionGoldman Sachs Group Inc
Latest Disclosed Ownership662,306 shares
Latest Disclosed Value $ 61,183,828
Goldman Sachs Group Inc reports 8.56% decrease in ownership of 08D / Mirum Pharmaceuticals, Inc.

On May 15, 2026 - Goldman Sachs Group Inc filed a 13F-HR form disclosing ownership of 662,306 shares of Mirum Pharmaceuticals, Inc. (DE:08D) valued at $49,672,950 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 724,317 shares of Mirum Pharmaceuticals, Inc.. This represents a change in shares of -8.56% during the quarter. The current value of the position is $51,077,039 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F MIRUM PHARMACEUTICALS CMN 604749101 662,306 -62,011 -8.56 61,184 6.94 0.0016
2026-02-10 2025-12-31 13F MIRUM PHARMACEUTICALS CMN 604749101 724,317 273,479 60.66 57,214 73.11 0.0071
2025-11-14 2025-09-30 13F MIRUM PHARMACEUTICALS CMN 604749101 450,838 55,830 14.13 33,051 64.42 0.0040
2025-08-14 2025-06-30 13F MIRUM PHARMACEUTICALS CMN 604749101 395,008 -82,643 -17.30 20,102 -6.59 0.0027
2025-06-27 2025-03-31 13F/A-2 MIRUM PHARMACEUTICALS CMN 604749101 477,651 -77,985 -14.04 21,518 -6.34 0.0035
2025-05-16 2025-03-31 13F/A-1 MIRUM PHARMACEUTICALS CMN 604749101 477,651 -77,985 21,518 0.0009
2025-05-09 2025-03-31 13F MIRUM PHARMACEUTICALS CMN 604749101 477,651 -77,985 21,518 0.0006
2025-02-11 2024-12-31 13F MIRUM PHARMACEUTICALS CMN 604749101 555,636 -82,331 -12.91 22,976 -7.66 0.0036
2024-11-14 2024-09-30 13F MIRUM PHARMACEUTICALS CMN 604749101 637,967 -121,051 -15.95 24,881 -4.12 0.0040
2024-08-13 2024-06-30 13F MIRUM PHARMACEUTICALS CMN 604749101 759,018 58,902 8.41 25,951 47.56 0.0044
2024-05-15 2024-03-31 13F MIRUM PHARMACEUTICALS CMN 604749101 700,116 243,798 53.43 17,587 30.56 0.0031
2024-05-14 2023-12-31 13F/A-2 MIRUM PHARMACEUTICALS CMN 604749101 456,318 215,542 89.52 13,471 77.05 0.0025
2024-03-01 2023-12-31 13F/A-1 MIRUM PHARMACEUTICALS CMN 604749101 456,318 215,542 13,471 0.0024
2024-02-13 2023-12-31 13F MIRUM PHARMACEUTICALS CMN 604749101 456,318 215,542 13,471 0.0006
2024-05-15 2023-09-30 13F/A-1 MIRUM PHARMACEUTICALS CMN 604749101 240,776 -34,120 -12.41 7,609 6.99 0.0016
2023-11-14 2023-09-30 13F MIRUM PHARMACEUTICALS CMN 604749101 240,776 -34,120 7,609 0.0015
2024-05-14 2023-06-30 13F/A-1 MIRUM PHARMACEUTICALS CMN 604749101 274,896 -117,476 -29.94 7,112 -24.54 0.0015
2023-08-15 2023-06-30 13F MIRUM PHARMACEUTICALS CMN 604749101 274,896 -117,476 7,112 0.0014
2024-05-14 2023-03-31 13F/A-1 MIRUM PHARMACEUTICALS CMN 604749101 392,372 -49,403 -11.18 9,425 9.40 0.0022
2023-05-11 2023-03-31 13F MIRUM PHARMACEUTICALS CMN 604749101 392,372 -49,403 9,425 0.0020
2024-05-14 2022-12-31 13F/A-1 MIRUM PHARMACEUTICALS CMN 604749101 441,775 205,747 87.17 8,615 215,250.00 0.0021
2023-02-13 2022-12-31 13F MIRUM PHARMACEUTICALS CMN 604749101 441,775 205,747 8,615 0.0019
2024-05-14 2022-09-30 13F/A-1 MIRUM PHARMACEUTICALS CMN 604749101 236,028 114,220 93.77 5 100.00 0.0013
2022-11-14 2022-09-30 13F MIRUM PHARMACEUTICALS CMN 604749101 236,028 114,220 4,959 0.0011
2024-05-14 2022-06-30 13F/A-2 MIRUM PHARMACEUTICALS CMN 604749101 121,808 93,071 323.87 2 -99.68 0.0006
2022-08-18 2022-06-30 13F/A-1 MIRUM PHARMACEUTICALS CMN 604749101 121,808 93,071 2,370 0.0005
2022-08-15 2022-06-30 13F MIRUM PHARMACEUTICALS CMN 604749101 121,808 93,071 2,370 0.0005
2022-05-16 2022-03-31 13F MIRUM PHARMACEUTICALS CMN 604749101 28,737 -12,536 -30.37 633 -3.80 0.0001
2022-02-17 2021-12-31 13F/A-1 MIRUM PHARMACEUTICALS CMN 604749101 41,273 41,273 658 0.0001
2022-02-14 2021-12-31 13F MIRUM PHARMACEUTICALS CMN 604749101 41,273 41,273 658 0.0000
2021-02-12 2020-12-31 13F MIRUM PHARMACEUTICALS CMN 604749101 0 -22,919 -100.00 0 -100.00
2020-11-13 2020-09-30 13F MIRUM PHARMACEUTICALS CMN 604749101 22,919 -8,021 -25.92 442 -26.58 0.0001
2020-08-12 2020-06-30 13F MIRUM PHARMACEUTICALS CMN 604749101 30,940 -7,177 -18.83 602 12.73 0.0002
2020-05-15 2020-03-31 13F MIRUM PHARMACEUTICALS CMN 604749101 38,117 38,117 534 0.0002
2020-02-14 2019-12-31 13F MIRUM PHARMACEUTICALS CMN 604749101 0 -11,066 -100.00 0 -100.00
2019-11-14 2019-09-30 13F MIRUM PHARMACEUTICALS CMN 604749101 11,066 11,066 111 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.